BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Doxorubicin
,
rs2476601
,
MDM2
,
Metabolism of xenobiotics
,
Diabetes mellitus
,
Kidney
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
iressa
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
FABP5
DDIT4
PRTN3
IGF1
MCM4
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_DN
PUJANA_BRCA1_PCC_NETWORK
PUJANA_CHEK2_PCC_NETWORK
KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_DN
CAIRO_HEPATOBLASTOMA_CLASSES_UP
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Acute myeloid leukemia primary cells and cell lines treated with Iressa
Explore Curated Studies Results
Literature
Most Relevant Literature
Synergistic inhibition of survival, proliferation, and migration of U87 cells with a combination of …
Epidermal growth factor receptor mutation analysis in previously unanalyzed histology samples and cy…
Discovery of 2',4'-dimethoxychalcone as a Hsp90 inhibitor and its effect on iressa-resistant non-sma…
Rationale and study design of the IRENE-trial (NVALT-16): a phase II trial to evaluate iressa rechal…
Crotoxin enhances the antitumor activity of gefinitib (Iressa) in SK-MES-1 human lung sq…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Arimidex/Faslodex/Iressa Study: A Trial Using Arimidex, Faslodex and Iressa in Women With Breast Can…
Open-Label Extension of Other SZ1839 (Iressa) Trials
Iressa as a First-Line Treatment in Chemonaive Patients With Inoperable Non-Small Cell Lung Cancer
Iressa (ZD1839) Plus Anastrozole (Arimidex) in Patients With Ovarian Cancer
Descriptive Pharmacoepidemiological Study of Patients Treated With Iressa
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ